- Home
- TELA vs TLPH Comparison
TELA vs TLPH Comparison
Compare TELA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TELA | TLPH |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7M | 37.9M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TELA | TLPH |
|---|---|---|
| Price | $0.70 | $0.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $3.31 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 334.2K | 162.3K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,300,000.00 | $2,151,000.00 |
| Revenue This Year | $18.41 | N/A |
| Revenue Next Year | $15.20 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.56 | N/A |
| 52 Week Low | $0.67 | $0.38 |
| 52 Week High | $2.73 | $1.57 |
Technical Indicators
Market Signals| Indicator | TELA | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 33.21 | 29.57 |
| Support Level | $0.75 | $0.78 |
| Resistance Level | $0.80 | $0.88 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 16.88 | 15.26 |
Price Performance
Historical ComparisonAbout TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.